MedPath

Dynesys Spinal System Post Market 522 Study

Not Applicable
Terminated
Conditions
Degenerative Spondylolisthesis
Pseudoarthrosis
Interventions
Device: Dynesys Spinal System
Registration Number
NCT01528072
Lead Sponsor
Zimmer Biomet
Brief Summary

The purpose of this study is to assess the safety and fusion rates following posterior lateral fusion with the Dynesys Spinal System used as an adjunct to fusion and compare to literature control.

Detailed Description

Study is meant to assess the safety and fusion rates following posterior lateral fusion with the Dynesys Spinal System.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
153
Inclusion Criteria
  1. Skeletally mature between the ages of 20-80
  2. Candidate for posterior lateral fusion between T1-S1 with autograft
  3. Degenerative spondylolisthesis with evidence of neurologic impairment or failed previous fusion (pseudoarthrosis)
  4. Symptoms of leg and/or back pain
  5. Non-responsive to conservative/non-surgical treatment for at least three (3) months
  6. Must be willing and able to comply with study requirements; including complete necessary study paperwork and return for required follow-up visits
Exclusion Criteria
  1. Active systemic or local infection
  2. Obesity
  3. Use of interbody device
  4. Pregnancy
  5. Mental illness
  6. Incarceration
  7. Alcohol or drug abuse
  8. Severe osteoporosis or osteopenia
  9. Use in the cervical spine
  10. Sensitivities/allergy to metals, polymers, polyethylene, polycarbonate urethane and polyethylene terephthalate
  11. Soft tissue deficit not allowing sound closure
  12. Any medical or physical condition that would preclude the potential benefit of spinal implant surgery
  13. Congenital abnormalities, tumors or other conditions that would prevent secure component fixation that has the potential to decrease the useful life of the device
  14. Active malignancy or other significant medical comorbidities
  15. Any medical or mental condition which would put the patient at high risk due to the severity of surgery
  16. Inadequate pedicles of the thoracic, lumbar and sacral vertebrae
  17. Patient unwilling or unable to follow postoperative instructions

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Dynesys SystemDynesys Spinal SystemAll patients will receive the Dynesys System and all patients will be compared to historical literature control. Dynesys Spinal System will be used for all subjects.
Primary Outcome Measures
NameTimeMethod
Fusion Rates24 months post surgery date

Fusion was defined by meeting three criteria:

* rotation \< 5° between motion segments on flexion-extension radiographs

* translation \< 3 mm between motion segments on flexion-extension radiographs

* presence of bridging bone. Fusion assessment for each patient was categorized as one of the four defined outcomes: fused, not fused, partial fusion, or UA (unable to assess). Efficacy was confirmed by the achievement of fusion in the experimental group when compared to the rate established in a literature control.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (9)

Greater Baltimore Medical Center

🇺🇸

Baltimore, Maryland, United States

Neurological Surgery of Southern Ill

🇺🇸

Belleville, Illinois, United States

Riverhills Healthcare, Inc

🇺🇸

Cincinnati, Ohio, United States

NYU - Center for Musculoskeletal Care

🇺🇸

New York, New York, United States

Pine Heights Medical Center

🇺🇸

Baltimore, Maryland, United States

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Danville Orthopedics and Spine

🇺🇸

Danville, Virginia, United States

OrthopaediCare

🇺🇸

Willow Grove, Pennsylvania, United States

Allegheny General Hospital

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath